13F-HR/A filed by EcoR1 Capital, LLC
EcoR1 Capital, LLC filed this 13F-HR/A for the quarter ended 2015-03-31, filed 2015-05-18, with 23 holding rows worth $300,071,000.
- Accession
- 0001140361-15-020512
- Filer
- CIK 1587114
- Filed
- 2015-05-18
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2015
A holdings report, amendment of type restatement, 24 entries on the cover page, a total value of $300,071,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $300,071,000 with VALUE read as thousands by filing date, 13F file number 028-16764. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 1,063,189 | $44,197,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 1,580,400 | $29,680,000 | thousands by filing date | |
| RECEPTOS, INC. | 756207106 | COMMON STOCK | 151,301 | $24,948,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC | 04269XAA3 | NOTE 3.000% 6/0 | 17,500,000 | $21,973,000 | thousands by filing date | principal |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 1,574,107 | $20,841,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464950 | PUT | 2,500 | $18,558,000 | thousands by filing date | put |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 243,048 | $18,041,000 | thousands by filing date | |
| KITE PHARMA INC | 49803L109 | COM | 281,400 | $16,231,000 | thousands by filing date | |
| FLEX PHARMA INC | 33938A105 | COM | 805,691 | $15,792,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 900,000 | $14,400,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 400,000 | $12,552,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 410,000 | $9,824,000 | thousands by filing date | |
| KINDRED BIOSCIENCES INC COM | 494577109 | Stock | 1,294,431 | $9,242,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 5,000 | $8,000,000 | thousands by filing date | call |
| GENVEC INC NEW | 37246C307 | cs | 1,986,413 | $5,860,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 112,455 | $5,649,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 7,350 | $5,417,000 | thousands by filing date | call |
| CALITHERA BIOSCIENCES INC COM NEW | 13089P101 | Stock | 295,480 | $4,852,000 | thousands by filing date | |
| FORWARD PHARMA A/S | 34986J105 | SPONSORED ADR | 158,985 | $4,502,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 220,570 | $3,720,000 | thousands by filing date | |
| FLEXION THERAPEUTICS INC | 33938J106 | COM | 162,900 | $3,669,000 | thousands by filing date | |
| TARGACEPT INC | 87611R306 | COM | 619,699 | $1,841,000 | thousands by filing date | |
| EPIZYME INC | 29428V904 | COM | 150 | $282,000 | thousands by filing date | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001140361-15-019963 | superseded | 2015-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001140361-15-020512 | this filing | 2015-05-18 | acceptance time not in the bulk data set |